Info

🌱 來自：double_hit_and_double_expressors_in_lymphoma

robust

activated B-cell-like (ABC) subtype

Nowakowski GS, Chiappella A, Gascoyne RD, et al. ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 2021;39(12):1317-1328. doi:10.1200/jco.20.01366